In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Improving Health Care Productivity Means ‘Locking Arms With Providers’

Philips is looking beyond COVID-19 and to building more partnership-based relationships in health care delivery

Executive Summary

Royal Philips would not routinely invest 10% of its sales in R&D without working with providers to discover their precise needs, says CEO Frans van Houten.

You may also be interested in...



The Balancing Act For HealthTech Providers In The Post-COVID-19 Era Of Volatility

How quickly health care delivery returns to pre-COVID-19 routines is the million-dollar question. With coronavirus volatility still a worrying reality and the burden of chronic care ever present, medtech companies that partner with provider systems must ensure they are covering all the bases. For Royal Philips’ Roy Jakobs, this means delivering on the promises of connected care.

Device Week, 7 August 2020: Brexit, COVID-19 & NHS Reform Augur Big 12 Months For UK Medtech

In this Device Week, Ashley Yeo asks PB Consulting managing director Dan Jones about the adjustments needed by UK medtechs as they face a confluence of change brought about by Brexit, COVID-19 and NHS reform, at a time when the MHRA is also coming under increased scrutiny. 

Carlo Rivis: Know Your Own Value In Bringing Disruptive Innovation To Market

Entrepreneur Carlo Rivis, one of In Vivo’s Rising Leaders, brought his disruptive innovation approaches to in-silico trials and digital avatar developer Computational Life, and now he is doing the same at Innovation Discovery.

Topics

Related Companies

UsernamePublicRestriction

Register

LL1123738

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel